DeSci is on fire, Binance Labs is favoring BIO, but what should we dig deeper into?

DeSci sounds like a grand concept, but to put it simply, it's about linking science with Web3, allowing scientific research to also engage in tokens, addressing long-standing issues such as insufficient funding, lack of data sharing, and transparency in research.

Speaking of BIO, it's not simple:

BIO has big ambitions, aiming to get patients, scientists, and biotech experts from around the world to contribute money and effort to biotech projects, while also tokenizing the intellectual property (IP) of these projects. This way, the market responds faster, and biotechnology can advance rapidly.

Binance Labs has a sharp eye; as soon as they saw DeSci gaining traction, they immediately invested in BIO, which is a solid move.

BIO also has the genes of a DAO; what are bioDAOs? They are teams focused on different scientific fields, such as researching rare diseases, hair loss, longevity, etc. BIO provides them with a set of professional support, making their DAO issuance protocols unique.

BIO also addresses liquidity issues, having built a secondary market where IP Tokens can be freely traded on decentralized exchanges like BIO Launchpad.

The BIO project is genuinely grounded. If DeSci can really establish a foothold in the traditional scientific community, it would be the next level of opportunity, comparable to AI. The winds of Web3 are already blowing, and DeSci is no exception; we might as well be bold, embrace the bubble, and who knows, we might catch a big fish!

BIO has a total supply of 3.32 billion, with 1.296 billion initially circulating. Binance Launchpool also holds a 3% share. Recently, new coins on Binance have performed well, and once BIO is launched, I'll provide everyone with a strategy for secondary trading.

For valuable insights in the crypto world, click on my profile to follow me for more information. Enjoy strategies for deploying high-potential coins in a bull market and daily spot trading!